{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:30:16Z","timestamp":1792477816454,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH126960"],"award-info":[{"award-number":["R01MH126960"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018727","name":"One Mind","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS113022"],"award-info":[{"award-number":["R21NS113022"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110649","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:45:00Z","timestamp":1755845100000},"page":"110649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Lithium restores inhibitory function and neuronal excitability through GSK-3\u03b2 inhibition in a bipolar disorder-associated Ank3 variant mouse model"],"prefix":"10.1016","volume":"279","author":[{"given":"Ren\u00e9 N.","family":"Caballero-Flor\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall P.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3977-1684","authenticated-orcid":false,"given":"Lia","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4207-5823","authenticated-orcid":false,"given":"Paul M.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110649_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.neuropharm.2025.110649_bib2","first-page":"1","article-title":"Spectrin- and ankyrin-based membrane domains and the evolution of vertebrates","volume":"72","author":"Bennett","year":"2013","journal-title":"Curr. Top. Membr."},{"key":"10.1016\/j.neuropharm.2025.110649_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2025.110649_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41398-022-01917-x","article-title":"Neural network of bipolar disorder: Toward integration of neuroimaging and neurocircuit-based treatment strategies","volume":"12","author":"Bi","year":"2022","journal-title":"Transl Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110649_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/pharmrev.120.000007","article-title":"New advances in the pharmacology and toxicology of lithium: a neurobiologically oriented overview","volume":"76","author":"Bortolozzi","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110649_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-neuro-062111-150444","article-title":"Mechanisms of gamma oscillations","volume":"35","author":"Buzsaki","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110649_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1906193","article-title":"Bipolar disorder","volume":"383","author":"Carvalho","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2025.110649_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f3646","article-title":"Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis","volume":"346","author":"Cipriani","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.neuropharm.2025.110649_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jad.2016.06.063","article-title":"Prevalence and correlates of cognitive impairment in euthymic adults with bipolar disorder: a systematic review","volume":"205","author":"Cullen","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2025.110649_bib9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1074\/jbc.M111.306472","article-title":"Evidence for irreversible inhibition of glycogen synthase kinase-3beta by tideglusib","volume":"287","author":"Dominguez","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110649_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.64","article-title":"Expression of GABAA alpha2-, beta1- and epsilon-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder","volume":"3","author":"Fatemi","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110649_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/syn.21973","article-title":"GABA(A) and GABA(B) receptor dysregulation in superior frontal cortex of subjects with schizophrenia and bipolar disorder","volume":"71","author":"Fatemi","year":"2017","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2025.110649_bib12","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ng.209","article-title":"Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder","volume":"40","author":"Ferreira","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2025.110649_bib13","first-page":"180","article-title":"The international college of neuro-psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines","volume":"20","author":"Fountoulakis","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110649_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.euroneuro.2021.10.003","article-title":"Lithium treatment of bipolar disorder in adults: a systematic review of randomized trials and meta-analyses","volume":"54","author":"Fountoulakis","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110649_bib15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/ejn.13923","article-title":"Treatment with the GSK3-beta inhibitor tideglusib improves hippocampal development and memory performance in juvenile, but not adult, Cdkl5 knockout mice","volume":"47","author":"Fuchs","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110649_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41398-018-0182-y","article-title":"Disruption of the psychiatric risk gene ankyrin 3 enhances microtubule dynamics through GSK3\/CRMP2 signaling","volume":"8","author":"Garza","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110649_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40345-016-0068-y","article-title":"Lithium side effects and toxicity: prevalence and management strategies","volume":"4","author":"Gitlin","year":"2016","journal-title":"Int J Bipolar Disord"},{"key":"10.1016\/j.neuropharm.2025.110649_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jad.2012.04.041","article-title":"Suicidal behavior in bipolar disorder: epidemiology, characteristics and major risk factors","volume":"143","author":"Gonda","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2025.110649_bib19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.euroneuro.2017.01.001","article-title":"Lithium reverses behavioral and axonal transport-related changes associated with ANK3 bipolar disorder gene disruption","volume":"27","author":"Gottschalk","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110649_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/nyas.13718","article-title":"Axon initial segments: structure, function, and disease","volume":"1420","author":"Huang","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2025.110649_bib21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1152\/physrev.00030.2024","article-title":"Axon initial segment structure and function in health and disease","volume":"105","author":"Jenkins","year":"2025","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110649_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2025.110649_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/mp.2010.43","article-title":"Genome-wide association study of bipolar I disorder in the han Chinese population","volume":"16","author":"Lee","year":"2011","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110649_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110649_bib25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/cn300110c","article-title":"Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo","volume":"3","author":"Morales-Garcia","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110649_bib26","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1038\/ncomms4339","article-title":"Genome-wide association study reveals two new risk loci for bipolar disorder","volume":"5","author":"Muhleisen","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110649_bib27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41588-021-00857-4","article-title":"Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology","volume":"53","author":"Mullins","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2025.110649_bib28","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1038\/s41380-018-0308-x","article-title":"Ankyrin-G regulates forebrain connectivity and network synchronization via interaction with GABARAP","volume":"25","author":"Nelson","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110649_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fncel.2017.00136","article-title":"Axonal membranes and their domains: assembly and function of the axon initial segment and node of ranvier","volume":"11","author":"Nelson","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110649_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2021.08.264","article-title":"Preventing new episodes of bipolar disorder in adults: systematic review and meta-analysis of randomized controlled trials","volume":"54","author":"Nestsiarovich","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110649_bib31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bdi.12805","article-title":"What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD\/IGSLI task force on treatment with lithium","volume":"21","author":"Nolen","year":"2019","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2025.110649_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jad.2016.02.018","article-title":"Trajectory and predictors of quality of life in first episode psychotic mania","volume":"195","author":"Oldis","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2025.110649_bib33","series-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research","author":"Organization","year":"1993"},{"key":"10.1016\/j.neuropharm.2025.110649_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/B978-0-7020-5307-8.00014-4","article-title":"Brain oscillations in bipolar disorder in search of new biomarkers","volume":"62","author":"Ozerdema","year":"2013","journal-title":"Suppl. Clin. neurophysiol."},{"key":"10.1016\/j.neuropharm.2025.110649_bib35","series-title":"Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2019"},{"key":"10.1016\/j.neuropharm.2025.110649_bib36","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s41386-022-01502-2","article-title":"Lithium rescues dendritic abnormalities in Ank3 deficiency models through the synergic effects of GSK3beta and cyclic AMP signaling pathways","volume":"48","author":"Piguel","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110649_bib37","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ng.943","article-title":"Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4","volume":"43","author":"Psychiatric GWAS Consortium Bipolar Disorder Working Group","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2025.110649_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1176\/ps.2009.60.2.147","article-title":"Premature mortality from general medical illnesses among persons with bipolar disorder: a review","volume":"60","author":"Roshanaei-Moghaddam","year":"2009","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.neuropharm.2025.110649_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12271","article-title":"International society for bipolar disorders task force on suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder","volume":"17","author":"Schaffer","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2025.110649_bib40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.schres.2015.02.002","article-title":"Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathology","volume":"167","author":"Schubert","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2025.110649_bib41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2009.05.025","article-title":"A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo","volume":"35","author":"Sereno","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2025.110649_bib42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1399-5618.2009.00706.x","article-title":"The history of lithium therapy","volume":"11","author":"Shorter","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2025.110649_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mcn.2018.04.010","article-title":"Ankyrins: roles in synaptic biology and pathology","volume":"91","author":"Smith","year":"2018","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110649_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ajmg.c.20013","article-title":"Family, twin, and adoption studies of bipolar disorder","volume":"123C","author":"Smoller","year":"2003","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.neuropharm.2025.110649_bib45","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41588-019-0397-8","article-title":"Genome-wide association study identifies 30 loci associated with bipolar disorder","volume":"51","author":"Stahl","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2025.110649_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.conb.2021.01.002","article-title":"Ankyrins and neurological disease","volume":"69","author":"Stevens","year":"2021","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110649_bib47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/19336950.2022.2120467","article-title":"Pleiotropic ankyrins: scaffolds for ion channels and transporters","volume":"16","author":"Stevens","year":"2022","journal-title":"Channels"},{"key":"10.1016\/j.neuropharm.2025.110649_bib48","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/73936","article-title":"Proximally targeted GABAergic synapses and gap junctions synchronize cortical interneurons","volume":"3","author":"Tamas","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110649_bib49","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.biopsych.2004.10.019","article-title":"Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains","volume":"57","author":"Torrey","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110649_bib50","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1073\/pnas.1417989112","article-title":"Giant ankyrin-G stabilizes somatodendritic GABAergic synapses through opposing endocytosis of GABAA receptors","volume":"112","author":"Tseng","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110649_bib51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1073\/pnas.1011824108","article-title":"Regulation of GABAergic synapse formation and plasticity by GSK3beta-dependent phosphorylation of gephyrin","volume":"108","author":"Tyagarajan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110649_bib52","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41398-023-02700-2","article-title":"Abnormal patterns of sleep and waking behaviors are accompanied by neocortical oscillation disturbances in an Ank3 mouse model of epilepsy-bipolar disorder comorbidity","volume":"13","author":"Villacres","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110649_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2025.110649_bib54","doi-asserted-by":"crossref","first-page":"10479","DOI":"10.1073\/pnas.1700689114","article-title":"Genetic disruption of ankyrin-G in adult mouse forebrain causes cortical synapse alteration and behavior reminiscent of bipolar disorder","volume":"114","author":"Zhu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:17:07Z","timestamp":1780028227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":55,"alternative-id":["S0028390825003570"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110649","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.26.564203","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lithium restores inhibitory function and neuronal excitability through GSK-3\u03b2 inhibition in a bipolar disorder-associated Ank3 variant mouse model","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110649"}}